98139-15-2 Usage
Uses
Used in Pharmaceutical Synthesis:
4-Aminopyridine-2-carbonitrile is utilized as an intermediate in the production of various pharmaceuticals, contributing to the development of new medications and therapeutic agents.
Used in Agrochemical Production:
4-AMINOPYRIDINE-2-CARBONITRILE also serves as an intermediate in the synthesis of agrochemicals, playing a role in the creation of products designed to protect crops and enhance agricultural yields.
Used in Neurological Disorder Treatment:
4-Aminopyridine-2-carbonitrile is studied for its potential use as a treatment for neurological disorders such as multiple sclerosis and Lambert-Eaton myasthenic syndrome. Its ability to enhance neurotransmission and improve muscle function makes it a promising candidate for these applications.
Used in Organic Synthesis:
As a building block in organic synthesis, 4-Aminopyridine-2-carbonitrile is employed in the production of a variety of fine chemicals, highlighting its importance in the chemical industry for creating specialized compounds with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 98139-15-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,1,3 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 98139-15:
(7*9)+(6*8)+(5*1)+(4*3)+(3*9)+(2*1)+(1*5)=162
162 % 10 = 2
So 98139-15-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H5N3/c7-4-6-3-5(8)1-2-9-6/h1-3H,(H2,8,9)
98139-15-2Relevant academic research and scientific papers
AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS AS EHMT1 AND EHMT2 INHIBITORS
-
Paragraph 0518; 0521-0522, (2017/11/10)
The present disclosure relates to amine-substituted aryl or heteroaryl compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., sickle cell anemia) via inhibition of a methyltransferase enzyme selected from EHMT1 and EHMT2, by administering an amine-substituted aryl or heteroaryl compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.
HETEROCYCLIC KINASE INHIBITORS
-
Page 131, (2010/02/08)
Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
